Zehra İlÇe Kaya

Zehra İlÇe Kaya

Auto-generated profile, based on publicly available information

Zehra İlÇe Kaya

HATAY MUSTAFA KEMAL ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ ENSTİTÜSÜ

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2024 in Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
Verified
Journal Article
Closed access
MTMenderes Yusuf Terzi
Menderes Yusuf Terzi
MKMeral Urhan Küçük
Meral Urhan Küçük
MYMüge Özsan Yılmaz
Müge Özsan Yılmaz
ZKZehra İlÇe Kaya
Zehra İlÇe Kaya
Type 2 diabetes (T2DM) is a complex, metabolic disease driven by genetic susceptibilities, environmental interactions, and various genes. Nowadays, increasing number of studies show the relationship between diabetes mellitus (DM) and epigenetics, especially DNA methylation. In this study, we aimed to measure the methylation levels of fat mass and obesity associated (FTO) and peroxisome proliferator activated receptor gamma (PPARG) in the peripheral blood samples of patients with clinical diagnosis of T2DM. In our study, whole blood was taken from T2DM patients (n=43) who applied to the Endocrinology Outpatient Clinic and from age-gender-matched healthy individuals (n=42). After the bisulfide conversion of isolated genomic DNAs from whole blood samples, the methylation profiles of target genes were analyzed with methyl-specific PCR and gel electrophoresis methods. Post-statistical analyses, no significant difference was found between the T2DM and control groups regarding FTO methylation status. The methylation level of PPARG gene in T2DM was significantly higher compared to the control group. Given the insulin sensitizing effects of PPARG, our findings confirm the possibility that methylation-mediated suppression of PPARG gene expression may lead to elevation of insulin resistance in T2DM patients. Further gene expression studies with more patients and quantitative methods will be required to better understand the effects of methylation in the PPARG gene in T2DM patients and its relationship to the disease.